These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22238785)

  • 1. Plummer-Vinson syndrome and reactive thrombocytosis mask a JAK2-V617F positive myeloproliferative neoplasm.
    Scott EC; Schuster S
    Blood; 2011 Dec; 118(23):5988. PubMed ID: 22238785
    [No Abstract]   [Full Text] [Related]  

  • 2. A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.
    Véronèse L; Tchirkov A; Richard-Pebrel C; Ledoux-Pilon A; Fleury J; Chaleteix C; Goumy C; Gouas L; Berger MG; Vago P; Bay JO; Tournilhac O
    Leuk Res; 2010 Apr; 34(4):e94-6. PubMed ID: 19833389
    [No Abstract]   [Full Text] [Related]  

  • 3. Splenomegaly and the JAK2 V617F mutation.
    Langabeer SE
    Eur J Intern Med; 2017 Jan; 37():e45-e46. PubMed ID: 27727073
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm.
    Eskazan AE; Salihoglu A; Diz-Kucukkaya R; Hancer VS; Soysal T
    Ann Hematol; 2012 Feb; 91(2):305-6. PubMed ID: 21584669
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
    Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
    Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
    Atallah E; Nussenzveig R; Yin CC; Bueso-Ramos C; Tam C; Manshouri T; Pierce S; Kantarjian H; Verstovsek S
    Leukemia; 2008 Jun; 22(6):1295-8. PubMed ID: 18059483
    [No Abstract]   [Full Text] [Related]  

  • 7. JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model.
    Brooks SA; Luty SB; Lai HY; Morse SJ; Nguyen TK; Royer LR; Agarwal A; Druker BJ; Fleischman AG
    Exp Hematol; 2016 Jan; 44(1):24-9.e1. PubMed ID: 26458983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and characteristics of the
    Ma Q
    J Int Med Res; 2020 Dec; 48(12):300060520977729. PubMed ID: 33307939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.
    Rapado I; Albizua E; Ayala R; Hernández JA; Garcia-Alonso L; Grande S; Gallardo M; Gilsanz F; Martinez-Lopez J
    Ann Hematol; 2008 Sep; 87(9):741-9. PubMed ID: 18575865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent
    Ye MT; Wang Y; Wang SA; Pemmaraju N; Daver N; Verstovsek S; Zhang Y; Zuo Z; Medeiros LJ; You MJ
    Leuk Lymphoma; 2020 Apr; 61(4):963-966. PubMed ID: 31750750
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
    Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY
    J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms.
    Siemiatkowska A; Bieniaszewska M; Hellmann A; Limon J
    Leuk Res; 2010 Mar; 34(3):387-9. PubMed ID: 19643476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.
    Benmoussa A; Dehbi H; Fehri S; Quessar A; Nadifi S
    Pathol Biol (Paris); 2011 Aug; 59(4):e89-92. PubMed ID: 19939582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilia and the JAK2 V617F Mutation.
    Langabeer SE; Haslam K
    Pathol Oncol Res; 2019 Jan; 25(1):437-438. PubMed ID: 28944411
    [No Abstract]   [Full Text] [Related]  

  • 15. JAK2-v617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms.
    Duletić AN; Dekanić A; Hadzisejdić I; Kusen I; Matusan-Ilijas K; Grohovac D; Grahovac B; Jonjić N
    Coll Antropol; 2012 Sep; 36(3):859-65. PubMed ID: 23213945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.
    Takata Y; Seki R; Kanajii T; Nohara M; Koteda S; Kawaguchi K; Nomura K; Nakamura T; Morishige S; Oku E; Osaki K; Hashiguchi E; Mouri F; Yoshimoto K; Nagafuji K; Okamura T
    Kurume Med J; 2014; 60(3-4):89-97. PubMed ID: 24858412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population.
    Nielsen C; Birgens HS; Nordestgaard BG; Bojesen SE
    Br J Haematol; 2013 Jan; 160(1):70-9. PubMed ID: 23116358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?
    Langabeer SE
    Eur J Intern Med; 2018 Jun; 52():e37-e38. PubMed ID: 29622375
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
    Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
    Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent refractory arterial thromboembolism associated with the Janus kinase 2 V617F mutation.
    Ali FR; Roberts LN; Mistry H; Patel RK; Edmondson RA; Arya R
    J Vasc Surg; 2009 Jan; 49(1):211-3. PubMed ID: 19174256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.